Toujeo (previously Optisulin) Unjoni Ewropea - Malti - EMA (European Medicines Agency)

toujeo (previously optisulin)

sanofi-aventis deutschland gmbh - insulina glargine - diabetes mellitus - drogi użati fid-dijabete - it-trattament tad-dijabete mellitus fl-adulti, l-adoloxxenti u t-tfal mill-età ta ' 6 snin.

Abasaglar (previously Abasria) Unjoni Ewropea - Malti - EMA (European Medicines Agency)

abasaglar (previously abasria)

eli lilly nederland b.v. - insulina glargine - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus f'adulti, adolexxenti u tfal ta 'sentejn u aktar.

Lusduna Unjoni Ewropea - Malti - EMA (European Medicines Agency)

lusduna

merck sharp & dohme b.v. - insulina glargine - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus f'adulti, adolexxenti u tfal ta 'sentejn u aktar.

Insulatard Unjoni Ewropea - Malti - EMA (European Medicines Agency)

insulatard

novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.

Protaphane Unjoni Ewropea - Malti - EMA (European Medicines Agency)

protaphane

novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.

Velosulin Unjoni Ewropea - Malti - EMA (European Medicines Agency)

velosulin

novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.

Semglee Unjoni Ewropea - Malti - EMA (European Medicines Agency)

semglee

viatris limited - insulina glargine - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus f'adulti, adolexxenti u tfal ta 'sentejn u aktar.

Lyumjev (previously Liumjev) Unjoni Ewropea - Malti - EMA (European Medicines Agency)

lyumjev (previously liumjev)

eli lilly nederland b.v. - insulina lispro - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus f'adulti, adolexxenti u tfal ta 'sena u aktar. trattament tad-dijabete mellitus fl-adulti.

Exubera Unjoni Ewropea - Malti - EMA (European Medicines Agency)

exubera

pfizer limited - insulin human - diabetes mellitus - drogi użati fid-dijabete - exubera hija indikata għat-trattament ta 'pazjenti adulti b'dijabete mellitus tip 2 notadequately kkontrollati ma' aġenti antidijabetiċi orali u li jeħtieġu terapija bl-insulina. exubera hija ukoll indikata għat-trattament ta 'pazjenti adulti b'dijabete mellitus tip 1, minbarra fit-tul intermedju jew li jaġixxu taħt il-ġilda' l-insulina, li għalihom il-benefiċċji potenzjali ofadding ta ' insulina inalata jisboq it-tħassib għas-sikurezza potenzjali (ara sezzjoni 4.

Suliqua Unjoni Ewropea - Malti - EMA (European Medicines Agency)

suliqua

sanofi winthrop industrie - l-insulina glargine, lixisenatide - diabetes mellitus, tip 2 - drogi użati fid-dijabete - suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without sglt-2 inhibitors.